FirmAtlas
Company handbook · KMB · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-17
KMB · CIK 55785 · LATEST FILING: 10-Q JUN '26 · FILED AUG 4, 2026
KIMBERLY-CLARK CORPORATION
$105.57
+1.50 (+1.44%)
Close, Oct 16, 2026 · 52-week $92–123
Last fiscal year
KIMBERLY-CLARK CORPORATION reported revenue of $16.4B for the year ended Dec 31, 2025 (FY25), down 2.1% from FY24. Net income was $2.0B, operating cash flow $2.8B and free cash flow $1.6B. Source: 10-K filed Feb 12, 2026.
Market cap
$35.0B
P/E
17.9
EV/EBITDA
12.9x
P/B
20.0
Div yield
4.83%
ROIC
23.8%
Revenue 1Y
−2.1%/yr
EPS 1Y
−19.6%/yr
Shares 1Y
+0.0%
Loading chart…
Median
Daily closes, split-adjusted · ratios at each fiscal year end
Company
CEOMichael D. Hsu
HQIrving, TX
AuditorDeloitte & Touche LLP
Employees36,000
Year endsDecember
Revenue by segment · FY25
North America NA65%
International Personal Care IPC35%
Compounded growth & averages
10Y
5Y
3Y
TTM
Share price
−1.3%
−4.6%
−4.6%
−11.8%
Upgrade to see 10 years
Share price: yearly compound rate of the traded close; the last column is the past year.
Where the cash went · FY24–FY25
$6.3B deployed
Capex
$1.9B
29.6%
Dividends
$3.3B
52.3%
Buybacks
$1.1B
18.1%
Operating cash flow over the period: $6.0B. Total debt changed by −$380M. R&D of $654M is already inside operating costs.
Growth engines
How much of the profit growth came from new investment, and how much from running the business better.
Upgrade to see 10 years
Financials
Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · change vs previous year
Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier
TTM = the last four quarters, to Jun '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.
Income
Revenue
16,805
16,447−2.1%
16,582
YoY
−2.1%
Gross profit
6,289
5,923−5.8%
6,095
Gross margin
37.4%
36.0%−1.4 pp
—
Operating income
2,700
2,351−12.9%
2,514
Operating margin
16.1%
14.3%−1.8 pp
—
EBITDA
3,481
3,156−9.3%
—
EBITDA margin
20.7%
19.2%−1.5 pp
—
Interest expense
270
256−5.2%
—
Interest coverage
12.89x
12.33x−0.56x
—
Net income
2,545
2,021−20.6%
1,955
YoY
−20.6%
Net margin
15.1%
12.3%−2.9 pp
—
EPS (diluted, $)
7.55
6.07−19.6%
5.88
YoY
−19.6%
Balance sheet
Total assets
16,546
17,098+3.3%
18,554
Cash & short-term investments
1,010
688−31.9%
—
Accounts receivable
1,728
1,892+9.5%
—
Inventory
1,452
1,475+1.6%
—
Net PP&E
6,284
6,775+7.8%
—
Other assets
6,072
6,268+3.2%
—
Total liabilities
15,706
15,596−0.7%
16,804
Accounts payable
3,264
3,388+3.8%
—
Total debt
6,854
6,474−5.5%
6,474
Other liabilities
5,588
5,734+2.6%
—
Shareholders’ equity
840
1,502+78.8%
1,750
Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.
Cash flow statement · as filed
Cash from operations
3,234
2,777−14.1%
3,333
Net income
2,578
2,049−20.5%
—
Depreciation & amortization
781
805+3.1%
—
Stock-based compensation
131
140+6.9%
—
Working capital & other
(256)
(217)n/m
—
Cash from investing
(100)
(951)n/m
—
Capex
(721)
(1,138)n/m
—
PP&E sold
651
33−94.9%
—
Acquisitions
0
—
—
Other investing
(30)
154n/m
—
Cash from financing
(3,166)
(2,179)n/m
—
Debt raised
0
0n/m
—
Debt repaid
(554)
(550)n/m
—
Dividends
(1,628)
(1,660)n/m
—
Buybacks
(1,000)
(141)n/m
—
Shares issued
136
40−70.6%
—
Other financing
(120)
132n/m
—
Net change in cash
(72)
(320)n/m
—
Free cash flow (OCF − capex)
2,513
1,639−34.8%
1,820
Where the cash went
Operating cash flow
3,234
2,777−14.1%
3,333
Reinvested in the business
721
1,138+57.8%
—
% of operating cash flow
22.3%
41.0%
Capex
721
1,138+57.8%
1,513
Acquisitions
0
—
—
R&D (memo, already in costs)
328
326−0.6%
—
Free cash flow
2,513
1,639−34.8%
1,820
YoY
−34.8%
Returned to shareholders
2,628
1,801−31.5%
—
% of free cash flow
104.6%
109.9%
Dividends
1,628
1,660+2.0%
—
Buybacks
1,000
141−85.9%
—
Change in total debt
—
(380)
—
Cash left over
—
(542)
—
FCF conversion (FCF ÷ net income)
98.7%
81.1%−17.6 pp
—
Owner earnings
—
1,625
—
Owner earnings margin
—
9.9%
—
Buyback yield
2.3%
0.4%−1.9 pp
—
Returns & ratios
ROIC (all capital)
34.3%
23.8%−10.5 pp
—
ROIC (operating)
37.0%
25.7%−11.3 pp
—
Net debt / EBITDA
1.68x
1.83x+0.15x
—
Debt / equity
8.16x
4.31x−3.85x
—
Cash conversion cycle (days)
−25
−24+1 d
—
ROE
303.0%
134.6%−168.4 pp
—
ROA
15.4%
11.8%−3.6 pp
—
ROCE
28.3%
23.6%−4.7 pp
—
NOPAT
2,292
1,665−27.4%
—
Invested capital (operating)
6,200
6,754+8.9%
—
Invested capital (all)
6,684
7,288+9.0%
—
Reinvestment rate
—
33.3%
—
Debtor days
38
42+4 d
—
Inventory days
50
51+1 d
—
Days payable
113
118+4 d
—
Income
Sep '25
Dec '25
Mar '26
Jun '26
Revenue
4,150
4,080
4,163
4,189
vs year-ago quarter
Gross profit
1,493
1,465
1,534
1,603
Gross margin
36.0%
35.9%
36.8%
38.3%
Operating income
621
507
753
633
Net income
446
499
665
345
vs year-ago quarter
Net margin
10.7%
12.2%
16.0%
8.2%
EPS (diluted, $)
1.34
1.50
2.00
1.04
vs year-ago quarter
Balance sheet
Sep '25
Dec '25
Mar '26
Jun '26
Total assets
16,888
17,098
17,184
18,554
Cash & equivalents
617
688
542
956
Total debt
6,470
6,474
6,475
6,474
Shareholders’ equity
1,332
1,502
1,796
1,750
Cash flow
Sep '25
Dec '25
Mar '26
Jun '26
Operating cash flow
708
972
745
908
Capex
340
397
424
352
Free cash flow
368
575
321
556
vs year-ago quarter